NewAmsterdam Pharma Company N.V. Reclassification Adjustments On Exchange Differences On Translation Net Of Tax
NewAmsterdam Pharma Company N.V. (NAMS) reported Reclassification Adjustments On Exchange Differences On Translation Net Of Tax of EUR 8.88 million for the 6-month period ending 2023-06-30, per its 6-K filed 2023-08-07.
Discontinued › Notes
ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax · last filed 2023-08-07
- 2023-06-30: Reclassification Adjustments On Exchange Differences On Translation Net Of Tax 6 month 8.88M EUR.
- 2022-06-30: Reclassification Adjustments On Exchange Differences On Translation Net Of Tax 6 month 0.00 EUR.
| Period end | Reclassification Adjustments On Exchange Differences On Translation Net Of Tax 6 month |
|---|---|
| 2023-06-30 | 8.88M EUR 6-K · filed 2023-08-07 |
| 2022-06-30 | 0.00 EUR 6-K · filed 2023-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |